Fatty liver is one of the most widespread liver conditions in the world, affecting people of many ages, backgrounds, and body types. It develops when excess fat builds up in liver cells, and it often causes no noticeable symptoms. Metabolic dysfunction-associated steatotic liver disease (MASLD), formerly called nonalcoholic fatty liver disease (NAFLD), is its most common form.
Recent research suggests that MASLD affects roughly one in three people in pooled study estimates, although the exact figure depends on who was studied and how the condition was measured. Other population-level models give lower numbers, which is why it matters to understand where each statistic comes from. Fatty liver is strongly linked to obesity, insulin resistance, and type 2 diabetes, so rates are especially high in people with these conditions.
This article explains how common fatty liver is, how prevalence is estimated, and which groups are most affected. Knowing the scale of the problem can support awareness, prevention, and earlier evaluation. The statistics describe populations, not individuals, and they do not replace advice from a healthcare professional.
What Is Fatty Liver Disease?
Understanding Fat Accumulation in the Liver
The liver processes nutrients, stores energy, and handles fats and sugars. Fatty liver, also called hepatic steatosis, occurs when too much fat collects in liver cells. This usually happens in the setting of excess weight, insulin resistance, or other metabolic problems.
Most people with early fatty liver feel fine, so the condition often goes unnoticed. The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) describes it as usually a silent disease with few or no symptoms. In some people, simple fat buildup (steatosis) stays stable, while in others it progresses to inflammation, scarring (fibrosis), and cirrhosis.
Types of Fatty Liver Disease
In 2023, liver societies introduced new terminology. NAFLD became MASLD, and nonalcoholic steatohepatitis (NASH) became metabolic dysfunction-associated steatohepatitis (MASH). The broader umbrella term is steatotic liver disease (SLD), as described in the EASL, EASD, and EASO guidelines.
- MASLD: Liver fat linked to metabolic risk factors such as obesity or type 2 diabetes.
- MASH: A more serious form of MASLD with inflammation and liver cell injury.
- Alcohol-associated liver disease (ALD): Liver fat and damage related to alcohol use.
- MetALD: Metabolic risk factors combined with higher alcohol intake.
SLD includes all of these, while MASLD refers only to the metabolic subtype. Older studies use NAFLD, which overlaps heavily with MASLD but is not identical.
How Common Is Fatty Liver Worldwide?
Fatty liver is very common worldwide. A 2025 systematic review and meta-analysis estimated that metabolic dysfunction-associated steatotic liver disease (MASLD) affects approximately 33.6% of the global population studied, or roughly one in three people. However, prevalence estimates vary depending on the population, diagnostic method, and definition used.
The meta-analysis, published in Clinical Gastroenterology and Hepatology, pooled 44 studies with about 11.28 million participants. It estimated that 37.5% of people had steatotic liver disease of any type. The table below shows the pooled estimates by subtype.
| Measure | Estimated prevalence |
|---|---|
| All steatotic liver disease | 37.5% |
| MASLD | 33.6% |
| MetALD | 4.1% |
| Alcohol-associated liver disease | 2.2% |
These are pooled averages, and the studies differed widely from one another. The authors reported very high statistical heterogeneity, meaning prevalence varied considerably by population, diagnostic approach, and study design. The categories should not be treated as simple add-on counts.
A different type of estimate comes from the Global Burden of Disease (GBD) 2023 analysis, published in The Lancet Gastroenterology & Hepatology in 2026. It estimated that about 1.3 billion people were living with MASLD in 2023, or 16.1% of the global population across all ages. This figure is lower than 33.6% because it uses different modeling methods and includes children and people of all ages, so the two numbers should not be compared directly.
Estimates also depend on the tool used. Ultrasound, MRI, blood-based scores, and biopsy can identify different numbers of cases, and studies in the general population differ from those in clinics or hospitals.
Is Fatty Liver Becoming More Common?
Yes, the number of people affected appears to be rising. The GBD analysis estimated that MASLD cases grew from about 500 million in 1990 to roughly 1.3 billion in 2023, an increase of about 143%. It also projected further growth by 2050.
Several trends help explain this:
- Rising obesity rates
- More people living with type 2 diabetes
- Sedentary lifestyles
- Changes in dietary patterns
- Increasing metabolic syndrome
Not all of the increase reflects worsening health. Population growth, aging, and better recognition of the disease also push case counts up. The GBD authors noted that the overall health impact has stayed fairly stable, which may reflect earlier detection and improved care.
The rise has not been identical everywhere. For example, the analysis found prevalence rates increased by about 22% in the United States and 33% in the United Kingdom between 1990 and 2023, with other regions showing different patterns.
How Common Is Fatty Liver in Different Regions of the World?
Prevalence differs by geography, and the numbers depend heavily on how each study was done. Regional figures are most reliable when the source names the population, diagnostic method, and study period.
Fatty Liver in Asia
Metabolic liver disease is a growing concern across many Asian populations. Urbanization, dietary change, and rising diabetes are often cited as contributors. Some people of Asian descent can develop MASLD at a lower body mass index (BMI) than people of other backgrounds, which is why BMI alone can miss risk.
Asia is also highly diverse. The GBD analysis found that the high-income Asia Pacific region had the lowest MASLD prevalence rate of any GBD region, so a single Asia-wide number would be misleading. Country-specific studies are more useful than global averages.
Fatty Liver in Europe and North America
MASLD is a substantial burden in Western countries, where obesity, diabetes, and metabolic syndrome are common. In the United States, one estimate cited with the FDA’s 2025 approval of Wegovy for MASH suggested that about 14.9 million adults, roughly 6%, have MASH, according to HealthDay. That figure refers to the more advanced inflammatory form, not all fatty liver.
Estimates vary between countries and studies because of differences in methods and populations.
Fatty Liver in Other Regions
The GBD analysis found that North Africa and the Middle East had higher MASLD prevalence rates than other regions with similar levels of development. Evidence from sub-Saharan Africa and some other regions is more limited. More consistent regional studies would give a clearer picture.
How Common Is Fatty Liver in People With Obesity and Diabetes?
Fatty liver is especially common in people with metabolic conditions, because insulin resistance and excess fat drive liver fat buildup. These are population-level findings, and they do not mean everyone with diabetes or obesity has fatty liver.
Fatty Liver in People With Type 2 Diabetes
The 2025 meta-analysis reported a pooled MASLD prevalence of 70.2% among people with type 2 diabetes. An earlier 2024 meta-analysis of NAFLD and MASLD in type 2 diabetes, published in the same journal, found a pooled prevalence of about 65%. Both show that most people with type 2 diabetes in these studies had fatty liver, even though the exact figures differ.
People with diabetes may also be more likely to have more advanced disease. That 2024 analysis found that a significant share of those with MASLD had advanced fibrosis. Managing blood sugar supports both diabetes and liver health, and our guide to managing type 2 diabetes is a good place to start.
Fatty Liver in People With Overweight or Obesity
The 2025 meta-analysis reported a pooled MASLD prevalence of 70.7% in overweight and obese populations. The confidence interval for this estimate was very wide (43.2% to 88.4%), which shows how much it varied between studies. Visceral fat and insulin resistance are key reasons for the high rates, as we explain in our guide to understanding insulin resistance.
BMI alone cannot tell whether someone has fatty liver. Some people with a high BMI have healthy livers, and some with a normal BMI do not.
How Common Is Fatty Liver in Men and Women?
The GBD analysis found that MASLD was more common in men than in women overall. However, patterns vary by population, age, and diagnostic criteria, so no single male-to-female ratio applies everywhere.
Several factors may play a role:
- Differences in metabolic risk factors and fat distribution
- Hormonal influences on where the body stores fat
- Possible effects of menopause on women’s metabolic health
The same analysis noted that the largest numbers of affected people were men around ages 35 to 39 and women around ages 55 to 59, while the highest prevalence rates were in older adults. This pattern suggests that risk shifts across the lifespan and differs by sex.
How Common Is Fatty Liver in Children and Young Adults?
Fatty liver is not limited to older adults. It can affect children, teenagers, and young adults, particularly when obesity and metabolic dysfunction are present.
Fatty Liver in Children and Teenagers
An AASLD practice statement on MASLD in children describes it as the most common cause of chronic liver disease in children and estimates global prevalence at around 7.6%. Childhood obesity, insulin resistance, and type 2 diabetes in younger people all raise the risk. Adult statistics should not be used to estimate rates in children, and any evaluation should be age-appropriate and guided by a pediatric clinician.
Fatty Liver in Young Adults
The GBD findings suggest that younger adults make up a large share of people with MASLD, especially in lower- and middle-income countries. Diet, inactivity, and rising metabolic risk can lead to liver fat before middle age. Building healthy habits early, such as through healthy weight management, may support long-term liver health.
Can People With Normal Weight Have Fatty Liver?
Yes. Lean or non-obese MASLD occurs in people with a normal BMI. Body weight alone cannot rule out fatty liver.
Contributing factors can include:
- Visceral fat accumulation
- Insulin resistance
- Genetic susceptibility
- Abnormal cholesterol and triglyceride levels
Metabolic risk can occur at lower BMI thresholds in Asian populations. The diagnostic criteria for MASLD use a BMI cutoff of about 23 for people of Asian descent, compared with 25 for others. For more detail, see our guide to fatty liver risk factors.
Why Is Fatty Liver So Common?
Fatty liver is common because its main drivers are common. Several factors often overlap:
- Increasing obesity and abdominal fat
- Type 2 diabetes and insulin resistance
- Diets high in added sugar and excess calories
- Physical inactivity
- Genetic susceptibility
- Metabolic syndrome and abnormal blood lipids
- Alcohol use, which can interact with metabolic risk
The GBD analysis found that high blood sugar was the leading risk factor tied to MASLD-related health loss, followed by high BMI. Most people develop fatty liver through a combination of metabolic and lifestyle influences rather than a single cause. Learn more about metabolic syndrome and how its features cluster.
Why Do Many People Have Fatty Liver Without Knowing It?
Early fatty liver rarely causes symptoms. When symptoms do occur, they may include fatigue or discomfort in the upper right abdomen, according to Mayo Clinic. Many people find out only after routine blood work or imaging done for another reason.
Liver enzyme tests can be normal even when fatty liver or significant scarring is present, so normal results do not rule it out. Ultrasound is often used to detect liver fat. For people at higher risk, clinicians may also estimate fibrosis with a blood-based score such as FIB-4 and, when appropriate, elastography, as described in the EASL guidelines.
The absence of symptoms does not necessarily mean the liver is healthy. If you have risk factors such as type 2 diabetes or obesity, ask your healthcare professional whether evaluation makes sense for you.
Is Fatty Liver a Serious Public Health Concern?
Yes, mainly because it is so common and can progress in some people. Fat buildup can lead to MASH, then fibrosis, and in some cases cirrhosis and liver-related complications. MASLD is also associated with cardiovascular disease, which is a leading concern for many affected people.
Chronic liver disease also adds to healthcare costs and demand. The GBD authors called for MASLD to be treated as a global health priority because of its scale and growth.
Most people with fatty liver do not automatically develop cirrhosis, and progression varies widely. Early recognition and healthy changes, such as those in our guide to fatty liver treatment options, can help lower the risk of complications for many people.
Frequently Asked Questions About Fatty Liver Prevalence
1. How common is fatty liver in the world?
A 2025 meta-analysis estimated global MASLD prevalence at 33.6%, or about one in three people in the populations studied. It estimated that 37.5% had steatotic liver disease of any kind, according to the published study.
2. What percentage of adults have fatty liver?
The percentage varies by study, population, and diagnostic method. The pooled MASLD estimate is about one-third, but individual studies range widely, and other models, such as the Global Burden of Disease analysis, report lower figures because they use different methods.
3. Is fatty liver more common in men or women?
Some studies, including the GBD analysis, found higher prevalence in men. Differences depend on age, metabolic risk, and the population studied, so patterns are not the same everywhere.
4. Is fatty liver common in people with diabetes?
Yes. The 2025 meta-analysis reported a pooled MASLD prevalence of 70.2% among people with type 2 diabetes. Earlier research found somewhat lower but still high rates.
5. Can young people develop fatty liver?
Yes. Children, teenagers, and young adults can develop fatty liver, particularly in association with obesity and metabolic dysfunction, as noted in AASLD’s pediatric practice statement.
6. Can you have fatty liver without symptoms?
Yes. Many people have no noticeable symptoms in the early stages and discover the condition through medical testing, according to NIDDK.
Final Thoughts: Understanding How Common Fatty Liver Is
Fatty liver is a widespread global health concern. Pooled research suggests MASLD affects about one-third of people in some estimates, while other models give lower population-wide numbers. Prevalence varies by country, age, metabolic health, and how the condition is measured, and it is especially high among people with diabetes and obesity.
To learn more about your own situation, consider reading about fatty liver risk factors and speaking with a qualified healthcare professional.
Sources
- Ho GJK, et al. High Global Prevalence of Steatotic Liver Disease and Associated Subtypes: A Meta-analysis. Clinical Gastroenterology and Hepatology, 2025
- GBD 2023 MASLD Collaborators. Global burden of MASLD, 1990 to 2023, and projections to 2050. The Lancet Gastroenterology & Hepatology, 2026
- Global Epidemiology of NAFLD and NASH Among Patients With Type 2 Diabetes. Clinical Gastroenterology and Hepatology, 2024
- AASLD Practice Statement on the Evaluation and Management of MASLD in Children. Hepatology, 2025
- EASL, EASD, EASO: Clinical Practice Guidelines on the Management of MASLD. Journal of Hepatology, 2024
- NIDDK: Symptoms and Causes of NAFLD and NASH
- Mayo Clinic: Fatty Liver Disease (MASLD), Symptoms and Causes
- HealthDay: FDA Approves Wegovy to Treat Serious Liver Disease
Medical Disclaimer: This article is for general education only and does not replace advice from a doctor or other qualified healthcare professional. Statistics describe groups of people and cannot show whether you personally have fatty liver. Talk with your healthcare provider about your own risk, testing, and any changes to your diet, exercise, or medications. Seek medical care promptly if you notice yellowing of the skin or eyes, severe abdominal pain, or swelling in the belly or legs.

4 thoughts on “How Common Is Fatty Liver? Prevalence, Statistics & Who Is at Risk”
Comments are closed.